Filing Details

Accession Number:
0001754526-23-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-20 15:59:45
Reporting Period:
2023-10-18
Accepted Time:
2023-10-20 15:59:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739426 Rvl Pharmaceuticals Plc RVLP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754526 Foundation Harsaul Edificio Afra
Avenida Samuel Lewis Y Calle 54
Panama R1
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-10-18 3,421,537 $0.06 19,063,760 No 4 S Indirect By Self as indirect owner of Altchem Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Self as indirect owner of Altchem Limited
Footnotes
  1. The price reported in Column 4 is a volume weighted average price. These shares were sold in multiple transactions at prices ranging from $0.0600 to $0.0678, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited.